Use of Combined Oral Contraceptives in Perimenopausal Women.
10.4068/cmj.2018.54.3.153
- Author:
Moon Kyoung CHO
1
Author Information
1. Department of Obstetrics and Gynecology, Research Institute of Medical Sciences, Chonnam National University Medical School, Gwangju, Korea. chomk@chonnam.ac.kr
- Publication Type:Review
- Keywords:
Female;
Contraceptives, Oral, Combined;
Perimenopause;
Risk Factors
- MeSH:
Breast Neoplasms;
Centers for Disease Control and Prevention (U.S.);
Colorectal Neoplasms;
Contraception;
Contraceptives, Oral, Combined*;
Endometrial Neoplasms;
Female;
Fertility;
Health Personnel;
Hemorrhage;
Humans;
Ovarian Neoplasms;
Perimenopause;
Pregnancy;
Risk Factors
- From:Chonnam Medical Journal
2018;54(3):153-158
- CountryRepublic of Korea
- Language:English
-
Abstract:
While perimenopausal women have low fecundity, they are still capable of becoming pregnant and the majority of pregnancies occurring during perimenopause are unintended pregnancies. Therefore, even during perimenopause, contraception must be used if unintended pregnancies are to be avoided. However, many perimenopausal women and healthcare providers believe that older people should not take combined oral contraceptives (COC) because doing so may be dangerous. However, to date, there is no evidence that taking COC presents an increased risk of cardiovascular events or breast cancer for middle-aged women as compared to other age groups, and in their recommendations, the Centers for Disease Control and Prevention (CDC) also do not list age itself as a contraindication for COC. Perimenopausal women often experience menstrual irregularity, heavy menstrual bleeding, and vasomotor symptoms. Taking COCs can help control these symptoms and significantly reduce the risk of ovarian cancer, endometrial cancer, and colorectal cancer. The objective of the present review is to examine the usage methods of COC among perimenopausal women and the health issues that may arise from taking COC in perimenopausal women.
